Marseille-Kliniken AG

euro adhoc: Marseille-Kliniken AG
other
- Further real estate deal signed - Sale of six care facilities for EUR 33.5 m

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

30.06.2008

Adhoc Release in accordance with section 15 of the German Securities Trading Act (WpHG)

Berlin, 30 June 2008. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has signed a sale-and-lease-back deal with a consortium of real estate investors, IMMAC Holding AG, Hamburg, as well as RP&C International / Public Service Properties Investments Ltd., London. Marseille-Kliniken AG has agreed a long-term lease for six care properties with a total of 567 beds with the investor consortium.

In total, the transaction has a volume of EUR 33.5 m and offers the company further financial scope to pursue its growth strategy in its core care business.

About 20% of Marseille-Kliniken AG´s portfolio consists of facilities it uses itself and about 80% which it has leased to other providers. The transaction will further reduce the company´s long-term financial debt.

The outlook for the financial year 2007/2008 dated 8 May 2008 is being confirmed. The company expects an annual turnover of EUR 233.5 m, an EBIT of EUR 24.0 m and a profit after tax of EUR 18.0 m.

End of adhoc release

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Marseille-Kliniken AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Marseille-Kliniken AG
Axel Hölzer
CEO
Alte Jakobstraße 79/80
10709 Berlin
GERMANY
Tel.: +4930 / 246 32-400
Fax:  +4930 / 246 32-401
www.marseille-kliniken.com

or

Hillermann Consulting
Christian Hillermann
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
GERMANY
Tel.: +4940 / 320 279 10
Fax:  +4940 / 320 279 114
www.hillermann-consulting.de

Branche: Pharmaceuticals
ISIN:      DE0007783003
WKN:        778300
Index:    CDAX, Classic All Share, Prime All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hamburg / regulated dealing



Weitere Meldungen: Marseille-Kliniken AG

Das könnte Sie auch interessieren: